GSA Capital Partners’s Viemed Healthcare VMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.46M Buy
127,591
+2,906
+2% +$28.8K 0.09% 294
2026
Q1
$1.15M Sell
124,685
-17,764
-12% -$148K 0.07% 411
2025
Q4
$1.06M Sell
142,449
-24,244
-15% -$166K 0.09% 328
2025
Q3
$1.13M Sell
166,693
-2,851
-2% -$19.3K 0.09% 323
2025
Q2
$1.17M Buy
169,544
+19,753
+13% +$134K 0.08% 363
2025
Q1
$1.09M Buy
149,791
+124,731
+498% +$979K 0.1% 302
2024
Q4
$201K Buy
25,060
+7,224
+41% +$62.7K 0.01% 1418
2024
Q3
$131K Buy
17,836
+4,829
+37% +$34.5K 0.01% 1465
2024
Q2
$85K Buy
+13,007
New +$98K 0.01% 1539

Other funds holding VMD

GSA Capital Partners's VMD Position: Q2 2026 in Review

GSA Capital Partners increased its Viemed Healthcare (VMD) stake by 2.3% in Q2 2026, buying an estimated $28.8K and bringing the position to 127,591 shares worth $1.46M. The position accounts for 0.09% of the portfolio, ranked #294.

GSA Capital Partners first reported a position in VMD in Q2 2024 and has held it in 9 quarters since. 166 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

  • GSA Capital Partners held 127,591 shares of Viemed Healthcare worth $1.46M as of Q2 2026.
  • GSA Capital Partners bought 2,906 Viemed Healthcare shares in Q2 2026, an estimated $28.8K.
  • Viemed Healthcare made up 0.09% of GSA Capital Partners's portfolio in Q2 2026, its #294 holding.
  • GSA Capital Partners first reported a position in Viemed Healthcare in Q2 2024 and has held it in 9 quarters since.
  • 166 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.